Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes
- 11 September 2002
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 9 (10) , 840-845
- https://doi.org/10.1038/sj.cgt.7700506
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovirCancer Gene Therapy, 2000
- Development of synthetic promoters for radiation-mediated gene therapyGene Therapy, 2000
- Experimental Gene Therapy for Brain Tumors Using Adenovirus-Mediated Transfer of Cytosine Deaminase Gene and Uracil Phosphoribosyltransferase Gene with 5-FluorocytosineHuman Gene Therapy, 2000
- In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirusCancer Gene Therapy, 2000
- Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transductionJournal of Neurosurgery, 1999
- Combined radiation and p53 gene therapy of malignant glioma cellsCancer Gene Therapy, 1999
- Concomitant expression ofE. colicytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosineFEMS Microbiology Letters, 1998
- Regional Delivery of an Adenovirus Vector Containing the Escherichia coli Cytosine Deaminase Gene to Provide Local Activation of 5-Fluorocytosine to Suppress the Growth of Colon Carcinoma Metastatic to LiverHuman Gene Therapy, 1996
- In VivoReplication-Deficient Adenovirus Vector-Mediated Transduction of the Cytosine Deaminase Gene Sensitizes Glioma Cells to 5-FluorocytosineHuman Gene Therapy, 1996
- In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-FluorocytosineHuman Gene Therapy, 1995